IRIS PHARMACHEM
IRIS PHARMACHEM, headquartered in India, is a prominent player in the pharmaceutical and chemical industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. Founded in 2005, the company has established a strong presence in key operational regions, including Asia, Europe, and North America. With a commitment to innovation and quality, IRIS PHARMACHEM offers a diverse range of products, including custom synthesis and contract manufacturing services. Their unique approach to research and development sets them apart, enabling them to meet the evolving needs of their clients. Recognised for their excellence, IRIS PHARMACHEM has achieved significant milestones, solidifying its position as a trusted partner in the global pharmaceutical supply chain.
DitchCarbon Score
How does IRIS PHARMACHEM's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
IRIS PHARMACHEM's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
IRIS PHARMACHEM's reported carbon emissions
IRIS PHARMACHEM, headquartered in India, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate initiatives. However, the company may still be engaged in industry-standard practices aimed at reducing environmental impact, although specific details are not provided. As the pharmaceutical sector increasingly focuses on sustainability, IRIS PHARMACHEM's future commitments and actions will be crucial in addressing climate change and reducing carbon emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
IRIS PHARMACHEM is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
